A dysgammaglobulinemia characterized by a deficiency of IMMUNOGLOBULIN G.
Phase 4 trials (2)
Phase 2 trials (1)
Organization Involved with Phase 4 Indications (3)
Organization Involved with Phase 3 Indications (2)
Organization Involved with Phase 2 Indications (4)